Patients' Experiences of Opioid Reduction

  • Research type

    Research Study

  • Full title

    Exploring Patients Experiences of Opioid Reduction in a Pain Medicine Department

  • IRAS ID

    336337

  • Contact name

    Helen Poole

  • Contact email

    h.m.poole@ljmu.ac.uk

  • Sponsor organisation

    Liverpool John Moores University

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    0 years, 9 months, 28 days

  • Research summary

    Patients with chronic non- cancer pain (CNCP) are frequently treated with opioids for pain relief. However, when taking high doses for long periods of time, patients may experience toxic side-effects and often no significant reduction in pain and improvement of quality of life. Recommendations from NICE and the Royal College of Anaesthetists state opioids are not advisable for CNCP and recommend their safe reduction or discontinuation, highlighting that patients need support during the process of reduction (NICE, 2021; Faculty of Pain of the Royal College of Anaesthetists, 2021).Patients often are referred to Hospital Pain Departments for detoxification of their opioid medication to safer dosages or no opioid medication. By interviewing patients who have been treated at a pain medicine department to reduce their opioids for chronic pain we aim to understand patients' experiences and views of the treatment received at the hospital and their journey in reducing opioids. Eligible patients will be over 18 years old, diagnosed with CNCP and currently taking opioids for CNCP.

  • REC name

    West Midlands - Black Country Research Ethics Committee

  • REC reference

    24/WM/0073

  • Date of REC Opinion

    20 Jun 2024

  • REC opinion

    Further Information Favourable Opinion